MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death

Molecular and Cellular Biology

Volumn 33, Issue 17, 2013, Pages 3494-3504

  Wong, Waihay J ^a,b   Qiu, Bo ^a,b   Nakazawa, Michael S ^a,b   Qing, Guoliang ^a,b,c   Simon, M Celeste ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CATHEPSIN S; MAX PROTEIN; MYC PROTEIN; PROTEASOME; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NOXA GENE; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUMA GENE;

ANIMALS; CATHEPSINS; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; KERATINOCYTES; MICE; OXYGEN; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84883534196     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00853-12     Document Type: Article

References (64)

1. Dang CV. 2010. Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer 1:526-531.
2. Vita M, Henriksson M. 2006. The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16:318-330.
3. Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, Brugge JS, Ramaswamy S. 2010. MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proc. Natl. Acad. Sci. U. S. A. 107:3698-3703.
4. Meyer N, Penn LZ. 2008. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8:976-990.
5. Herkert B, Eilers M. 2010. Transcriptional repression: the dark side of myc. Genes Cancer 1:580-586.
6. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. 2003. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421: 290-294.
7. Steiger D, Furrer M, Schwinkendorf D, Gallant P. 2008. Maxindependent functions of Myc in Drosophila melanogaster. Nat. Genet. 40:1084-1091.
8. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20-26.
9. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424 - 2433.
10. Nakano K, Vousden KH. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7:683-694.
11. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
12. Boone DN, Qi Y, Li Z, Hann SR. 2011. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc. Natl. Acad. Sci. U. S. A. 108:632-637.
13. Nikiforov MA, Riblett M, Tang W-H, Gratchouck V, Zhuang D, Fernandez Y, Verhaegen M, Varambally S, Chinnaiyan AM, Jakubowiak AJ, Soengas MS. 2007. Tumor cell-selective regulation of NOXA by c- MYC in response to proteasome inhibition. Proc. Natl. Acad. Sci. U. S. A. 104:19488-19493.
14. Brunelle JK, Santore MT, Budinger GRS, Tang Y, Barrett TA, Zong W-X, Kandel E, Keith B, Simon MC, Thompson CB, Hay N, Chandel NS. 2004. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1. J. Biol. Chem. 279:4305-4312.
15. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
16. Klefstrom J, Västrik I, Saksela E, Valle J, Eilers M, Alitalo K. 1994. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13:5442-5450.
17. Shim H, Chun YS, Lewis BC, Dang CV. 1998. A unique glucosedependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. U. S. A. 95:1511-1516.
18. Sears R, Leone G, DeGregori J, Nevins JR. 1999. Ras enhances Myc protein stability. Mol. Cell 3:169-179.
19. Yuan J, Minter-Dykhouse K, Lou Z. 2009. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J. Cell Biol. 185:203-211.
20. Conacci-Sorrell M, Ngouenet C, Eisenman RN. 2010. Myc-Nick: a cytoplasmic cleavage product of Myc that promotes α-tubulin acetylation and cell differentiation. Cell 142:480-493.
21. Small GW, Chou T-Y, Dang CV, Orlowski RZ. 2002. Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch. Biochem. Biophys. 400:151-161.
22. Carmeliet P, Jain RK. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307.
23. Majmundar AJ, Wong WJ, Simon MC. 2010. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40:294-309.
24. Denko NC. 2008. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8:705-713.
25. Mazure NM, Pouysségur J. 2010. Hypoxia-induced autophagy: cell death or cell survival? Curr. Opin. Cell Biol. 22:177-180.
26. Gordan JD, Bertout JA, Hu C-J, Diehl JA, Simon MC. 2007. HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell 11:335-347.
27. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL. 2008. HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14:435- 446.
28. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. 2004. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23:1949-1956.
29. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL. 2007. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11:407-420.
30. Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, Dicker DT, El-Deiry WS. 2005. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol. Ther. 4:1285-1294.
31. Koshiji M, To KK-W, Hammer S, Kumamoto K, Harris AL, Modrich P, Huang LE. 2005. HIF-1+ induces genetic instability by transcriptionally downregulating MutS+ expression. Mol. Cell 17:793-803.
32. To KK-W, Sedelnikova OA, Samons M, Bonner WM, Huang LE. 2006. The phosphorylation status of PAS-B distinguishes HIF-1+ from HIF-2+ in NBS1 repression. EMBO J. 25:4784-4794.
33. Lichti U, Anders J, Yuspa SH. 2008. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3:799-810.
34. Forsberg EC, Downs KM, Bresnick EH. 2000. Direct interaction of NF-E2 with hypersensitive site 2 of the β-globin locus control region in living cells. Blood 96:334-339.
35. Li Q, Kluz T, Sun H, Costa M. 2009. Mechanisms of c-Myc degradation by nickel compounds and hypoxia. PLoS One 4:e8531. doi:10.1371 /journal.pone.0008531.
36. Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, Simon MC. 2010. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res. 70:10351-10361.
37. Kress TR, Cannell IG, Brenkman AB, Samans B, Gaestel M, Roepman P, Burgering BM, Bushell M, Rosenwald A, Eilers M. 2011. The MK5/ PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol. Cell 41:445-457.
38. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. 2006. The colorectal microRNAome. Proc. Natl. Acad. Sci. U. S. A. 103:3687-3692.
39. Tsao CC, Teh BT, Jonasch E, Shreiber-Agus N, Efstathiou E, Hoang A, Czerniak B, Logothetis C, Corn PG. 2008. Inhibition of Mxi1 suppresses HIF-2+-dependent renal cancer tumorigenesis. Cancer Biol. Ther. 7:1619-1627.
40. Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, Eilers M. 1997. An alternative pathway for gene regulation by Myc. EMBO J. 16: 5672-5686.
41. Hann SR, Eisenman RN. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
42. Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6:797- 805.
43. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, Kogel U, Scheffner M, Helin K, Eilers M. 2005. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123: 409-421.
44. Choi SH, Wright JB, Gerber SA, Cole MD. 2010. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev. 24:1236-1241.
45. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. 2003. Skp2 regulates Myc protein stability and activity. Mol. Cell 11:1177-1188.
46. Popov N, Schulein C, Jaenicke LA, Eilers M. 2010. Ubiquitylation of the amino terminus of Myc by SCFβ-TrCP antagonizes SCFFbw7-mediated turnover. Nat. Cell Biol. 12:973-981.
47. Von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, Söderberg O, Kerppola TK, Larsson L-G. 2003. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Mycregulated transcription. Mol. Cell 11:1189-1200.
48. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. 2004. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23:2116-2125.
49. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C. 2004. Inactivation of hCDC4 can cause chromosomal instability. Nature 428:77-81.
50. Dang CV, Kim J-W, Gao P, Yustein J. 2008. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8:51-56.
51. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501-2514.
52. Kaidi A, Williams AC, Paraskeva C. 2007. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9:210- 217.
53. Arsham AM, Howell JJ, Simon MC. 2003. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278:29655-29660.
54. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WG. 2004. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893-2904.
55. Wall M, Poortinga G, Hannan KM, Pearson RB, Hannan RD, McArthur GA. 2008. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood 112:2305-2317.
56. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. U. S. A. 97:9082- 9087.
57. Kim J-Y, Ahn H-J, Ryu J-H, Suk K, Park J-H. 2004. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1+. J. Exp. Med. 199:113-124.
58. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. 2003. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:1931-1936.
59. Pelengaris S, Khan M, Evan GI. 2002. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109:321-334.
60. Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. 2001. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21:7653- 7662.
61. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Mycinduced lymphomagenesis. Genes Dev. 13:2658-2669.
62. Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE, Yue W, Yu J, Zhang L, Onciu M, Sample JT, Cleveland JL, Zambetti GP. 2008. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol. Cell. Biol. 28:5391-5402.
63. Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. 1999. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:2670-2677.
64. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. 2005. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436:807-811.